Neurosense Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.78

+0.03 (+3.42%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +4,412.0% upside

Low Target $27.84

Average Target $35.23

High Target $57.14

Current Price $0.78

Current
$0.78

Target
$35.23

$27.84 $35.23 avg $57.14

Scenario Analysis

Bear Case

$27.84

3,465.6%

Low target

Base Case

$35.23

+4,412.0%

Avg target

Bull Case

$57.14

+7,218.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.60

-70.0% from high

52-Week Low

$0.63

+23.9% from low

Target vs 52W High

$35.23

+1,255.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%